{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:38:20Z","timestamp":1784115500144,"version":"3.55.0"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.pharep.2018.03.011","type":"journal-article","created":{"date-parts":[[2018,3,30]],"date-time":"2018-03-30T18:50:40Z","timestamp":1522435840000},"page":"900-907","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Bisphosphonates: Future perspective for neurological disorders"],"prefix":"10.1007","volume":"70","author":[{"given":"Saima","family":"Zameer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9299-414X","authenticated-orcid":false,"given":"Abul Kalam","family":"Najmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1852-9191","authenticated-orcid":false,"given":"Divya","family":"Vohora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"1","key":"10.1016\/j.pharep.2018.03.011_bib0005","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1056\/NEJMoa0802633","article-title":"Giant osteoclast formation and long-term oral bisphosphonate therapy","volume":"360","author":"Weinstein","year":"2009","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.pharep.2018.03.011_bib0010","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1056\/NEJMp1202619","article-title":"Bisphosphonates for osteoporosis- where do we go from here?","volume":"366","author":"Whitaker","year":"2012","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.pharep.2018.03.011_bib0015","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S1286-4579(00)01272-7","article-title":"The role of immune responses in bone loss during periodontal disease","volume":"2","author":"Baker","year":"2000","journal-title":"Microbes Infect"},{"issue":"5484","key":"10.1016\/j.pharep.2018.03.011_bib0020","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","article-title":"Bone resorption by osteoclasts","volume":"289","author":"Teitelbaum","year":"2000","journal-title":"Science"},{"issue":"9319","key":"10.1016\/j.pharep.2018.03.011_bib0025","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","article-title":"Epidemiology and outcomes of osteoporotic fractures","volume":"359","author":"Cummings","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.pharep.2018.03.011_bib0030","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bone.2013.09.023","article-title":"Update on long-term treatment with bisphosphonates for postmenopausal osteoporosis: a systematic review","volume":"58","author":"Eriksen","year":"2014","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.pharep.2018.03.011_bib0035","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3109\/09513590.2013.813468","article-title":"Systematic review and meta-analysis of the efficacy and safety of alendronate and zoledronate for the treatment of postmenopausal osteoporosis","volume":"29","author":"Serrano","year":"2013","journal-title":"Gynecol Endocrinol"},{"issue":"32","key":"10.1016\/j.pharep.2018.03.011_bib0040","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.2174\/1381612033453640","article-title":"New insights into the molecular mechanisms of action of bisphosphonates","volume":"9","author":"Rogers","year":"2003","journal-title":"Curr Pharm Des"},{"issue":"6","key":"10.1016\/j.pharep.2018.03.011_bib0045","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00223-004-0024-1","article-title":"From molds and macrophages to mevalonate: a decade of progress in understanding the molecular mode of action of bisphosphonates","volume":"75","author":"Rogers","year":"2004","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"10.1016\/j.pharep.2018.03.011_bib0050","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0022-3565(24)38786-5","article-title":"Structure\u2013activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates","volume":"296","author":"Dunford","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharep.2018.03.011_bib0055","first-page":"31","article-title":"Bisphosphonates and alendronate","volume":"31","author":"Karamustafa","year":"2006","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.pharep.2018.03.011_bib0060","first-page":"85","article-title":"Mevalonate pathway: role of bisphosphonates and statins","volume":"27","author":"Mansueto","year":"2011","journal-title":"Acta Med Mediterr"},{"issue":"6","key":"10.1016\/j.pharep.2018.03.011_bib0065","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.bone.2007.02.019","article-title":"Effects of statins on bone mineral density: a meta-analysis of clinical studies","volume":"40","author":"Uzzan","year":"2007","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.pharep.2018.03.011_bib0070","first-page":"2","article-title":"Historical perspectives on the clinical development of bisphosphonates in the treatment of bone diseases","volume":"7","author":"Francis","year":"2007","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.pharep.2018.03.011_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/1426279","article-title":"An evaluative history of bisphosphonate drugs: dual physiologic effects of pyrophosphate as inspiration for a novel pharmaceutical class","volume":"10","author":"Hinshaw","year":"2016","journal-title":"J Osteoporos"},{"issue":"3","key":"10.1016\/j.pharep.2018.03.011_bib0080","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1021\/j150549a005","article-title":"The solubility of bone mineral. II. Precipitation of near-neutral solutions of calcium and phosphate","volume":"61","author":"Strates","year":"1957","journal-title":"J Phys Chem"},{"issue":"10","key":"10.1016\/j.pharep.2018.03.011_bib0085","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1152\/ajplegacy.1962.203.4.671","article-title":"Isolation from urine of pyrophosphate, a calcification inhibitor","volume":"203","author":"Fleisch","year":"1962","journal-title":"Am J Physiol"},{"issue":"5065","key":"10.1016\/j.pharep.2018.03.011_bib0090","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/212901a0","article-title":"Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis","volume":"212","author":"Fleisch","year":"1966","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.pharep.2018.03.011_bib0095","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1152\/ajplegacy.1966.211.3.821","article-title":"Effect of condensed phosphates on calcification of chick embryo femurs in tissue culture","volume":"211","author":"Fleisch","year":"1966","journal-title":"Am J Physiol"},{"issue":"1","key":"10.1016\/j.pharep.2018.03.011_bib0100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/BF02065192","article-title":"The influence of pyrophosphate analogues (diphosphonates) on the precipitation and dissolution of calcium phosphate in vitro and in vivo","volume":"2","author":"Fleisch","year":"1968","journal-title":"Calcif Tissue Res"},{"issue":"1","key":"10.1016\/j.pharep.2018.03.011_bib0105","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/BF02012561","article-title":"The effect of two diphosphonates on the resorption of mouse calvaria in vitro","volume":"10","author":"Reynolds","year":"1972","journal-title":"Calcif Tissue Res"},{"issue":"6","key":"10.1016\/j.pharep.2018.03.011_bib0110","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1152\/ajplegacy.1970.218.6.1757","article-title":"Fate of intravenously injected pyrophosphate-32P in dogs","volume":"218","author":"Jung","year":"1970","journal-title":"Am J Physiol"},{"issue":"4","key":"10.1016\/j.pharep.2018.03.011_bib0115","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1507\/endocrj1954.16.415","article-title":"Pyrophosphate enhancement of thyrocalcitonin effect in tissue culture","volume":"16","author":"Orimo","year":"1969","journal-title":"Endocrinol Jpn"},{"key":"10.1016\/j.pharep.2018.03.011_bib0120","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/B978-1-4832-3119-8.50010-X","article-title":"The formation and influence of surface phases on calcium phosphate solids","volume":"3","author":"Francis","year":"1968","journal-title":"Adv Oral Biol"},{"issue":"1","key":"10.1016\/j.pharep.2018.03.011_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02546591","article-title":"The effect of phosphonates on dental enamel in vitro and calculus formation in vivo","volume":"11","author":"Francis","year":"1973","journal-title":"Calcif Tissue Res"},{"issue":"1","key":"10.1016\/j.pharep.2018.03.011_bib0130","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF02058658","article-title":"The inhibition of calcium hydroxyapatite crystal growth by polyphosphonates and polyphosphates","volume":"3","author":"Francis","year":"1969","journal-title":"Calcif Tissue Res"},{"issue":"3899","key":"10.1016\/j.pharep.2018.03.011_bib0135","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1126\/science.165.3899.1262","article-title":"Diphosphonates inhibit hydroxyapatite in vitro and bone resorption in tissue culture and in vivo","volume":"165","author":"Fleisch","year":"1969","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pharep.2018.03.011_bib0140","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF02061949","article-title":"The effect of disodium ethane-1-hydroxy-1,1-diphosphonate on adjuvant induced arthritis in rats","volume":"9","author":"Francis","year":"1972","journal-title":"Calcif Tissue Res"},{"key":"10.1016\/j.pharep.2018.03.011_bib0145","series-title":"The role of phosphonates in living systems","first-page":"55","author":"Francis","year":"1983"},{"issue":"3899","key":"10.1016\/j.pharep.2018.03.011_bib0150","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1126\/science.165.3899.1264","article-title":"Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcificaation in vivo","volume":"165","author":"Francis","year":"1969","journal-title":"Science"},{"issue":"7625","key":"10.1016\/j.pharep.2018.03.011_bib0155","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0140-6736(69)92293-4","article-title":"Diphosphonates in the treatment of myositis ossificans","volume":"2","author":"Bassett","year":"1969","journal-title":"Lancet"},{"issue":"7706","key":"10.1016\/j.pharep.2018.03.011_bib0160","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(71)91447-4","article-title":"Diphosphonates and Paget\u2019s disease of bone","volume":"297","author":"Smith","year":"1971","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.pharep.2018.03.011_bib0165","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.genhosppsych.2012.11.008","article-title":"The challenging interpretation of genetic and neuroimaging features in basal ganglia calcification","volume":"35","author":"Oliveira","year":"2013","journal-title":"Gen Hosp Psychiatry"},{"issue":"6","key":"10.1016\/j.pharep.2018.03.011_bib0170","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng.3289","article-title":"Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export","volume":"47","author":"Legati","year":"2015","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.pharep.2018.03.011_bib0175","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/humu.22778","article-title":"Update and mutational analysis of SLC20A2: a major cause of primary familial brain calcification","volume":"36","author":"Lemos","year":"2015","journal-title":"Hum Mutat"},{"issue":"9","key":"10.1016\/j.pharep.2018.03.011_bib0180","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/ng.2723","article-title":"Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice","volume":"45","author":"Keller","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharep.2018.03.011_bib0185","doi-asserted-by":"crossref","first-page":"22961","DOI":"10.1038\/srep22961","article-title":"Primary brain calcification in patients undergoing treatment with the biphosphanate alendronate","volume":"6","author":"Oliveira","year":"2016","journal-title":"Sci Rep"},{"issue":"1\u20132","key":"10.1016\/j.pharep.2018.03.011_bib0190","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jns.2005.11.033","article-title":"Brain calcifications induce neurological dysfunction that can be reversed by a bone drug","volume":"243","author":"Loeb","year":"2006","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.pharep.2018.03.011_bib0195","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1440-1673.2003.01110.x","article-title":"Intracranial Tc99m MDP uptake in Sturge\u2013Weber syndrome","volume":"47","author":"Hui","year":"2003","journal-title":"Australas Radiol"},{"key":"10.1016\/j.pharep.2018.03.011_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-83668-8_1","article-title":"Bisphosphonates: a new class of drugs in diseases of bone and calcium metabolism","volume":"116","author":"Fleisch","year":"1989","journal-title":"Recent Results Cancer Res"},{"issue":"4","key":"10.1016\/j.pharep.2018.03.011_bib0205","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jtemb.2014.08.010","article-title":"Oesteoporosis in neurodegeneration","volume":"28","author":"Roos","year":"2014","journal-title":"J Trace Elem Med Biol"},{"key":"10.1016\/j.pharep.2018.03.011_bib0210","first-page":"34","article-title":"Alzheimer\u2019s disease and osteoporosis\u2013correlation increasing the risk of life-threatening fractures?","volume":"2","author":"Bednarski","year":"2014","journal-title":"Med Tube Sci"},{"key":"10.1016\/j.pharep.2018.03.011_bib0215","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bone.2014.01.010","article-title":"Amyloid beta peptide is elevated in osteoporotic bone tissues and enhances osteoclast function","volume":"61","author":"Li","year":"2014","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.pharep.2018.03.011_bib0220","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/jbmr.1954","article-title":"Swedish mutant APP suppresses osteoblast differentiation and causes osteoporotic deficit, which are ameliorated by N-acetyl-L-cysteine","volume":"28","author":"Xia","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.pharep.2018.03.011_bib0225","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s11357-013-9608-x","article-title":"Increased risk of dementia in patients with osteoporosis: a population- based retrospective cohort analysis","volume":"36","author":"Chang","year":"2014","journal-title":"Age (Dordr)"},{"issue":"3","key":"10.1016\/j.pharep.2018.03.011_bib0230","first-page":"346","article-title":"Comparison of non-vertebral fracture between minodronate and risedronate therapy in elderly female patients with Alzheimer disease","volume":"13","author":"Sato","year":"2013","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"1","key":"10.1016\/j.pharep.2018.03.011_bib0235","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3233\/JAD-150979","article-title":"Streptozotocin induces mild cognitive impairment at appropriate doses in mice as determined by long-term potentiation and the morris water maze","volume":"54","author":"Li","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.pharep.2018.03.011_bib0240","article-title":"Oxidative stress, Protein modification and Alzheimer\u2019s disease","author":"Tramutola","year":"2016","journal-title":"Brain Res Bull"},{"issue":"4","key":"10.1016\/j.pharep.2018.03.011_bib0245","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3233\/JAD-2008-15412","article-title":"Potential mechanisms linking cholesterol to Alzheimer\u2019s disease-like pathology in rabbit brain, hippocampal organotypic slices, and skeletal muscle","volume":"15","author":"Ghribi","year":"2008","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"10.1016\/j.pharep.2018.03.011_bib0250","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/0006-8993(83)91273-8","article-title":"The isolation and amino acid composition of senile plaque core protein","volume":"3259","author":"Allsop","year":"1998","journal-title":"Brain Res"},{"issue":"8","key":"10.1016\/j.pharep.2018.03.011_bib0255","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1212\/01.wnl.0000240127.89601.83","article-title":"Aging of the brain, entropy, and Alzheimer disease","volume":"67","author":"Drachman","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.pharep.2018.03.011_bib0260","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer\u2019s disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol Rev"},{"issue":"2","key":"10.1016\/j.pharep.2018.03.011_bib0265","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archpsyc.62.2.217","article-title":"Do statins reduce risk of incident dementia and Alzheimer diseae? The Cache cohort study","volume":"62","author":"Zandi","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharep.2018.03.011_bib0270","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.arr.2016.03.008","article-title":"Cholesterol metabolism: a review of how ageing disrupts the biological mechanisms responsible for its regulation","volume":"27","author":"Morgan","year":"2016","journal-title":"Ageing Res Rev"},{"issue":"6257","key":"10.1016\/j.pharep.2018.03.011_bib0275","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate Pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharep.2018.03.011_bib0280","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12035-012-8253-1","article-title":"Isoprenoids and related pharmacological interventions: potential application in Alzheimer\u2019s disease","volume":"46","author":"Li","year":"2012","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.pharep.2018.03.011_bib0285","first-page":"908","article-title":"Statins and the prevention of dementia","volume":"165","author":"Das","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.pharep.2018.03.011_bib0290","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00018-005-5298-6","article-title":"Isoprenylated proteins","volume":"63","author":"McTaggart","year":"2016","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"10.1016\/j.pharep.2018.03.011_bib0295","doi-asserted-by":"crossref","first-page":"455","DOI":"10.33549\/physiolres.931382","article-title":"Alendronate lowers cholesterol synthesis in the central nervous system of rats \u2013 a preliminary study","volume":"58","author":"Cibickova","year":"2009","journal-title":"Physiol Res"},{"issue":"4","key":"10.1016\/j.pharep.2018.03.011_bib0300","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.mcn.2010.08.001","article-title":"Hypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits","volume":"45","author":"Ullrich","year":"2010","journal-title":"Mol Cell Neurosci"},{"issue":"6","key":"10.1016\/j.pharep.2018.03.011_bib0305","doi-asserted-by":"crossref","first-page":"765","DOI":"10.33549\/physiolres.931121","article-title":"Differential effects of statins and alendronate on cholinesterases in serum and brain of rats","volume":"56","author":"Cibickova","year":"2007","journal-title":"Physiol Res"},{"issue":"1\u20132","key":"10.1016\/j.pharep.2018.03.011_bib0310","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0006-8993(02)02981-5","article-title":"Inactivation of the human brain muscarinic acetylcholine receptor by oxidative damage catalyzed by a low molecular weight endogenous inhibitor from Alzheimer\u2019s brain is prevented by pyrophosphate analogs, bioflavonoids and other antioxidants","volume":"950","author":"Fawcett","year":"2002","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.pharep.2018.03.011_bib0315","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.nbd.2009.05.005","article-title":"Regulation of the brain isoprenoids farnesyl- and geranylgeranyl pyrophosphate is altered in male Alzheimer patients","volume":"35","author":"Eckert","year":"2009","journal-title":"Neurobiol Dis"},{"issue":"6","key":"10.1016\/j.pharep.2018.03.011_bib0320","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1139\/y2012-076","article-title":"Reciprocal regulation of cholesterol and beta amyloid at the subcellular level in Alzheimer\u2019s disease","volume":"99","author":"Posse de Chaves","year":"2012","journal-title":"Can J Physiol Pharmacol"},{"issue":"1","key":"10.1016\/j.pharep.2018.03.011_bib0325","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s12035-012-8337-y","article-title":"Role of cholesterol in APP metabolism and its significance in Alzheimer\u2019s disease pathogenesis","volume":"47","author":"Maulik","year":"2013","journal-title":"Mol Neurobiol"},{"issue":"4","key":"10.1016\/j.pharep.2018.03.011_bib0330","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00216-008-2306-3","article-title":"Isoprenoid quantitation in human brain tissue: a validated HPLC-fluorescence detection method for endogenous farnesyl- (FPP) and geranylgeranyl pyrophosphate (GGPP)","volume":"392","author":"Hooff","year":"2008","journal-title":"Anal Bioanal Chem"},{"issue":"6","key":"10.1016\/j.pharep.2018.03.011_bib0335","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0197-4580(90)90024-T","article-title":"Cortical senile plaques in coronary artery disease, aging and Alzheimer\u2019s disease","volume":"11","author":"Sparks","year":"1990","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.1016\/j.pharep.2018.03.011_bib0340","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/exnr.1994.1044","article-title":"Induction of Alzheimer-like \u03b2-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol","volume":"126","author":"Sparks","year":"1994","journal-title":"Exp Neurol"},{"issue":"2","key":"10.1016\/j.pharep.2018.03.011_bib0345","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1212\/01.WNL.0000149519.47454.F2","article-title":"Midlife cardiovascular risk factors and risk of dementia in late life","volume":"64","author":"Whitmer","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.pharep.2018.03.011_bib0350","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bcp.2012.12.007","article-title":"Cerebral and extracerebral cholesterol metabolism and CSF markers of Alzheimer\u2019s disease","volume":"86","author":"Popp","year":"2013","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"10.1016\/j.pharep.2018.03.011_bib0355","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/archinte.163.9.1053","article-title":"Plasma total cholesterol level as a risk factor for Alzheimer disease","volume":"163","author":"Tan","year":"2003","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.pharep.2018.03.011_bib0360","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","article-title":"Thematic review series: brain Lipids: cholesterol metabolism in the central nervous system during early development and in the mature animal","volume":"45","author":"Dietschy","year":"2004","journal-title":"J Lipid Res"},{"issue":"10","key":"10.1016\/j.pharep.2018.03.011_bib0365","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/jcbfm.2013.135","article-title":"Blood-brain barrier dysfunction as cause and consequence of Alzheimer\u2019s disease","volume":"33","author":"Erickson","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4852","key":"10.1016\/j.pharep.2018.03.011_bib0370","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.pharep.2018.03.011_bib0375","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1096\/fj.02-0285fje","article-title":"Function of beta-amyloid in cholesterol transport: a lead to neurotoxicity","volume":"16","author":"Yao","year":"2002","journal-title":"FASEB J"},{"issue":"6085","key":"10.1016\/j.pharep.2018.03.011_bib0380","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1219988","article-title":"The amyloid precursor protein has a flexible transmembrane domain and binds cholesterol","volume":"336","author":"Barrett","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.pharep.2018.03.011_bib0385","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/glia.21001","article-title":"Altered levels and distribution of amyloid precursor protein and its processing enzymes in Niemann\u2013Pick type C1- deficient mouse brains","volume":"11","author":"Kodam","year":"2010","journal-title":"Glia"},{"issue":"8","key":"10.1016\/j.pharep.2018.03.011_bib0390","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/1044549041562285","article-title":"Regulation of cytokine receptor signaling by nuclear hormone receptors: a new paradigm for receptor interaction","volume":"23","author":"Leung","year":"2004","journal-title":"DNA Cell Biol"},{"issue":"7","key":"10.1016\/j.pharep.2018.03.011_bib0395","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1038\/npp.2015.357","article-title":"High fat diet induced anxiety and anhedonia: impact on brain homeostasis and inflammation","volume":"41","author":"Dutheil","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pharep.2018.03.011_bib0400","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1471-4159.2008.05415.x","article-title":"High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice","volume":"106","author":"Thirumangalakudi","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharep.2018.03.011_bib0405","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bbr.2016.06.012","article-title":"Detrimental effects of a high fat\/high cholesterol diet on memory and hippocampal markers in aged rats","volume":"312","author":"Ledreux","year":"2016","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharep.2018.03.011_bib0410","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neuint.2014.06.012","article-title":"Mechanism of synapse redox stress in okadaic acid (ICV) induced memory impairment: role of NMDA receptor","volume":"76","author":"Kamat","year":"2014","journal-title":"Neurochem Int"},{"issue":"19\u201320","key":"10.1016\/j.pharep.2018.03.011_bib0415","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.lfs.2012.03.012","article-title":"A study on neuroinflammatory marker in brain areas of okadaic acid (ICV) induced memory impaired rats","volume":"90","author":"Kamat","year":"2012","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.pharep.2018.03.011_bib0420","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.pharep.2018.03.011_bib0425","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/030097498441155","article-title":"Bisphosphonates inhibit IL-6 production by human osteoblast-like cells","volume":"27","author":"Olmos","year":"1998","journal-title":"Scand J Rheumatol"},{"issue":"11","key":"10.1016\/j.pharep.2018.03.011_bib0430","first-page":"2318","article-title":"Evaluation of bone turnover and osteoclastic cytokines in early rheumatoid arthritis treated with alendronate","volume":"26","author":"Cantatore","year":"1999","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.pharep.2018.03.011_bib0435","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1007\/s12035-013-8591-7","article-title":"Mutations of the huntington\u2019s disease protein impact on the ATM-dependent signaling and repair pathways of the radiation-induced DNA double-strand breaks: corrective effect of statins and bisphosphonates","volume":"49","author":"Ferlazzo","year":"2014","journal-title":"Moln Neurobiol"},{"key":"10.1016\/j.pharep.2018.03.011_bib0440","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/B978-0-12-385883-2.00010-2","article-title":"Huntington disease and the huntingtin protein","volume":"107","author":"Zheng","year":"2013","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"3","key":"10.1016\/j.pharep.2018.03.011_bib0445","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/mrdd.1022","article-title":"Juvenile onset Huntington\u2019s disease\u2014clinical and research perspectives","volume":"7","author":"Nance","year":"2001","journal-title":"Ment Retard Dev Disabil Res Rev"},{"issue":"9557","key":"10.1016\/j.pharep.2018.03.011_bib0450","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington\u2019s disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.pharep.2018.03.011_bib0455","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1152\/physrev.1999.79.2.425","article-title":"Chaperone-mediated protein folding","volume":"79","author":"Fink","year":"1999","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharep.2018.03.011_bib0460","series-title":"Effectiveness of statin and bisphosphonate treatment in a 3NP model of Huntington\u2019s disease. University of New Orleans Theses and Dissertations","author":"Kelley","year":"2015"},{"issue":"5","key":"10.1016\/j.pharep.2018.03.011_bib0465","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"10.1016\/j.pharep.2018.03.011_bib0470","first-page":"559","article-title":"The small GTP-binding protein, Rhes, regulates signal transduction from G protein-coupled receptors","volume":"23","author":"Vargiu","year":"2004","journal-title":"Oncopene"},{"key":"10.1016\/j.pharep.2018.03.011_bib0475","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.brainres.2008.09.066","article-title":"Ontogeny and dopaminergic regulation in brain of Ras homolog enriched in striatum (Rhes)","volume":"1245","author":"Harrison","year":"2008","journal-title":"Brain Res"},{"issue":"5932","key":"10.1016\/j.pharep.2018.03.011_bib0480","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1126\/science.1172871","article-title":"Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity","volume":"324","author":"Subramaniam","year":"2009","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.pharep.2018.03.011_bib0485","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1523\/JNEUROSCI.3730-12.2013","article-title":"Rhes deletion is neuroprotective in the 3-nitropropionic acid model of Huntington\u2019s disease","volume":"33","author":"Mealer","year":"2013","journal-title":"J Neurosci"},{"issue":"Suppl. 5","key":"10.1016\/j.pharep.2018.03.011_bib0490","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1097\/IJG.0b013e3182934aca","article-title":"The microglial system in the eye and brain in response to stimuli in vivo","volume":"22","author":"Ellis-Behnke","year":"2013","journal-title":"J Glaucoma"},{"issue":"9","key":"10.1016\/j.pharep.2018.03.011_bib0495","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1046\/j.1460-9568.1999.00808.x","article-title":"Proliferation of microglia and astrocytes in the dentate gyrus following entorhinal cortex lesion: a quantitative bromodeoxyuridine-labelling study","volume":"11","author":"Hailer","year":"1999","journal-title":"Eur J Neurosci"},{"issue":"8","key":"10.1016\/j.pharep.2018.03.011_bib0500","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.it.2008.05.002","article-title":"Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression","volume":"29","author":"Gao","year":"2008","journal-title":"Trends Immunol"},{"issue":"39","key":"10.1016\/j.pharep.2018.03.011_bib0505","first-page":"105","article-title":"Activated microglia in Alzheimer\u2019s disease and stroke","author":"Pocock","year":"2002","journal-title":"Ernst Schering Res Found Workshop"},{"key":"10.1016\/j.pharep.2018.03.011_bib0510","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.expneurol.2004.06.010","article-title":"Clodronate inhibits the secretion of proinflammatory cytokines and NO by isolated microglial cells and reduces the number of proliferating glial cells in excitotoxically injured organotypic hippocampal slice cultures","volume":"189","author":"Dehghani","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pharep.2018.03.011_bib0515","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s11064-015-1761-4","article-title":"Neuroprotective effects of etidronate and 2,3,3-trisphosphonate against glutamate-induced toxicity in PC12 cell","volume":"41","author":"Li","year":"2016","journal-title":"Neurochem Res"},{"issue":"5","key":"10.1016\/j.pharep.2018.03.011_bib0520","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/sj.bjp.0706373","article-title":"The inhibitory effect of alendronate, a nitrogen-containing bisphosphonate on the PI3K\u2013Akt\u2013NF\u03baB pathway in osteosarcoma cells","volume":"146","author":"Inoue","year":"2005","journal-title":"Br J Pharmacol"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114017308253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114017308253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:37:37Z","timestamp":1752611857000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2018.03.011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":104,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1734114017308253"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2018.03.011","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bisphosphonates: Future perspective for neurological disorders","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2018.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}